Small pharma firms may face closure as regulator tightens quality checks

Many small drug makers face closure as regulators inspect facilities for quality standards. Thousands of plants may shut down if upgrades are not made. This could lead to drug shortages. Industry groups are seeking more time to comply. The government has set a deadline for these upgrades. Companies must submit plans for improvement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Pv6ZORL
via IFTTT